| Nov 1 |
AbbVie Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
| Nov 1 |
AbbVie and EvolveImmune Therapeutics sign oncology collaboration
|
| Nov 1 |
5 Stocks That Recently Announced Dividend Hikes
|
| Nov 1 |
Regeneron battles Wall Street uncertainty; Madrigal extends fast launch of MASH drug
|
| Nov 1 |
Eli Lilly's Zepbound sales, Pfizer wants in on weight loss drugs, AbbVie's big deal: Pharma news round up
|
| Oct 31 |
AbbVie and EvolveImmune Therapeutics Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Cancer Biotherapeutics
|
| Oct 31 |
AbbVie announces 2025 dividend increase of 5.8% to $1.64 from $1.55 per share
|
| Oct 31 |
5 Dividend Stocks to Double Up on Right Now -- Plus Some Dividend ETFs
|
| Oct 31 |
AbbVie Inc (ABBV) Q3 2024 Earnings Call Highlights: Strong Growth in Ex-Humira Platform and ...
|
| Oct 31 |
Q3 2024 AbbVie Inc Earnings Call
|
